FDA Approved: GOCOVRI — Supplemental Application (Adamas Pharma, LLC)

View source ↗

Summary

FDA approved a supplemental application for GOCOVRI (amantadine) submitted by Adamas Pharma, LLC. The approval relates to the use of GOCOVRI for tardive dyskine…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tardive Dyskinesia

Drugs mentioned

• Gocovri (amantadine extended-release)

Snippet

SUPPL AP for GOCOVRI (AMANTADINE)